Abstract
Background/Objectives: Diabetes is frequent among cancer patients. Diabetes and cancer co-occurrence may result in a worse prognosis and complications in cancer patients. This systematic review aims to investigate the impact of glycemic control in patients having both cancer and diabetes. Methods: PubMed, Web of Science, Science Direct, and Google Scholar were systematically searched to include the relevant literature. Rayyan QRCI was used throughout this systematic approach. Results/ Interpretation: A total of thirteen studies with 13550 patients were included in this review. The reported follow-up duration ranged from 2 to 12 months. Cancer patients with diabetes are more likely to get infections, be hospitalized, and require chemotherapy reductions or discontinuation. Having cancer with comorbid diabetes affects diabetes self-management and results in poor glycemic control. Applying clinical pharmaceutical programs to raise awareness about compliance with diabetic medication along with cancer treatment was found to have positive outcomes. Evidence-based practice recommendations or policies should be developed that advocate assessing diabetes patients' glycemic state at the time of cancer diagnosis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Saudi Journal of Medical and Pharmaceutical Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
